| QCGAX | VIMSX | QCGAX / VIMSX | |
| Total Expense Ratio | 2.24 | 0.17 | 1,318% |
| Annual Report Gross Expense Ratio | 2.24 | 0.17 | 1,318% |
| Fund Existence | 2 years | 28 years | - |
| Gain YTD | 8.005 | 10.324 | 78% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 3000 | 333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 101M | 226B | 0% |
| Annual Yield % from dividends | 0.33 | 1.18 | 28% |
| Returns for 1 year | 10.31 | 9.70 | 106% |
| Returns for 3 years | N/A | 49.61 | - |
| Returns for 5 years | N/A | 32.50 | - |
| Returns for 10 years | N/A | 157.41 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VRGWX | 977.53 | 6.36 | +0.65% |
| Vanguard Russell 1000 Growth Index I | |||
| BIRAX | 25.63 | 0.01 | +0.04% |
| BlackRock Sust Awr Advtg Lg Cp Cr Inv A | |||
| QCACX | 49.51 | 0.01 | +0.02% |
| Federated Hermes MDT All Cap Core C | |||
| MLNAX | 30.15 | -0.11 | -0.36% |
| Morgan Stanley Instl Glbl Concntr A | |||
| NSMRX | 39.46 | -0.29 | -0.73% |
| Nuveen Small/Mid-Cap Value I | |||